Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
oncr-177 (1 trial)
pembrolizumab (keytruda) (1 trial)
Neoplasms (Phase 1)
Squamous Cell Carcinoma of Head and Neck (Phase 1)
Trials (1 total)
Trial APIs (2 total)